Skip to main content
SpringerLink
Log in

The Early Treatment of Inflammatory Bowel Disease

  • Chapter
Origins and Directions of Inflammatory Bowel Disease

  • 73 Accesses

Abstract

Past therapeutic approaches to ulcerative colitis and Crohn’s disease reflected prevailing limitations in the understanding of human illness and scarce therapeutic resources. Early in the 1900s the treatment of IBD included “slop diets,” three pints daily of milk soured by lactic acid (Sydenham’s treatment), “bacterial vaccines,” astringents, antiseptics, calomel, starch and opium, tincture of hamamelis, tincture of iodine, and rectal instillations of boracic acid, silver nitrate, creolin, iron pernitrate, or kerosene.1 Strange therapy to physicians in the year 2002, but hardly as bizarre as the approach of earlier times to diarrhea and the associated problems as described in the following:2

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allchin WH. Ulcerative colitis. An address introductory to the subject. Proc Roy Soc Med 1909;2:59–75.

    PubMed  CAS  Google Scholar 

  2. Haggard H. The doctors in history - New Haven 1934. In: MacKinney LC, ed. Baltimore: Johns Hopkins Press, 1937:33–4.

    Google Scholar 

  3. Dack GM, Dragstedt LR. Effect of introducing oxygen into isolated colon of patient with chronic ulcerative colitis. Am J Dig Dis 1938;5:84–6.

    CAS  Google Scholar 

  4. Meleney FL. In discussion of L. R. Dragstedt, G. M. Dack, J. B. Kirsner. Chronic ulcerative colitis. Ann Surg l94l;114:653–62.

    Google Scholar 

  5. Curtius F. Hypnotische behandlung schwerer colitiden. Dtsch Arch Klin Med 1943;190:444–56.

    Google Scholar 

  6. Dorfman W. Narco analysis in ulcerative colitis. NY State J Med 1952;52:2019–21.

    CAS  Google Scholar 

  7. Popp WC, Bargen JA, Dixon CF. Regional enteritis - roentgen therapy. Proc Mayo Clin 1950;25:1–5.

    CAS  Google Scholar 

  8. Logan AH. Three cases of chronic ulcerative colitis cured by iodine. Med Clin North Am 1923;7:105–12.

    Google Scholar 

  9. Herfort RA, Livingston H. Thiouracil drugs in treatment of chronic ulcerative colitis. NY State J Med 1952;52:431–6.

    CAS  Google Scholar 

  10. Burnford J. Ulcerative colitis - its treatment by ionization - summary of twenty eight cases. Br Med J 1930;2:640–1.

    PubMed  CAS  Google Scholar 

  11. Cheney G. Injection of highly concentrated liver extract in treatment of idiopathic ulcerative colitis. Arch Intern Med 1939;63:813–29.

    CAS  Google Scholar 

  12. Ferguson LK, Fetter K, Schnabel TG. Artificial fever in the treatment of ulcerative colitis: A preliminary report. Am J Dig Dis 1937;4:487–8.

    Google Scholar 

  13. Schmelkes FD, Marks HC. N,N-Dichloro-azao-dicarbomidine (azochloramid), an n-chloro deriviatve of oxidant in an oxidation-reduction system. J Am Chem Soc 1934;56:1610–13.

    CAS  Google Scholar 

  14. Goffrey Y, Colin R, Hacketsweiler PH, Segrestin M. Traitement de la maladie de Crohn per le BCG. Arch Mal l’Appareil Dig 1971;64:299–308.

    Google Scholar 

  15. Burnham WR, Lennard-Jones JE, Hecketsweiler P, Colin R, Geffroy Y. Oral BCG vaccine in Crohns disease. Gut 1979;20:229–33.

    PubMed  CAS  Google Scholar 

  16. Portis S, Block L, Necheles H. Studies on chronic ulcerative colitis and some biological effects of detergents. Gastroenterology 1944;3:106–13.

    CAS  Google Scholar 

  17. Horgan E, Horgan J. Chronic ulcerative colitis - results of treatment with vaccine in 5 cases. JAMA 1929;93:263–6.

    Google Scholar 

  18. Lups S. Vaccine therapy in ulcerative colitis. Am J Dig Dis Nutr 1935;2:65–90.

    Google Scholar 

  19. Maratka Z, Wagner F. The treatment of nonspecific ulcerative colitis by autogenous vaccine: correlated bacteriological and immunological studies. Gastroenterology 1948;113:34–49.

    Google Scholar 

  20. Kalk H. Therapie der colitis gravis durch erzeugung von anaphylaxis und mit bluttransfusionen. Ztsch f Klin Med 1931 ;118:560–83.

    Google Scholar 

  21. Gill AM. Chronic ulcerative colitis clinical experiments with pig’s intestine. Lancet 1944:246:536–7.

    Google Scholar 

  22. Ehrlich R. Treatment of chronic ulcerative colitis with fractional component of hog’s stomach. Am J Dig Dis Nutr l950;17:1–4.

    CAS  Google Scholar 

  23. Streicher MH, Grossman MI, Ivy AC. Preliminary report of a clinical trial of orally administered hog duodenum powder in the treatment of chronic ulcerative colitis. Gastroenterology 1949:12:371–4.

    PubMed  CAS  Google Scholar 

  24. Friedman MHF, Haskell BF. Treatment of nonspecific ulcerative colitis for one year with extracts of intestinal mucosa. Gastroenterology 1946;11:833–41.

    Google Scholar 

  25. Hiatt B. Abnormal intestinal motility as an etiological factor in inflammatory bowel disease. J Clin Gastroenterol 1984;6:201–3.

    PubMed  CAS  Google Scholar 

  26. Schlitt RJ, McNally JJ, Shafiroff BGP, Hinton JW. Pelvic autonomic neurectomy for ulcerative colitis. Gastroenterology 1951 ;19:812–16.

    PubMed  CAS  Google Scholar 

  27. Dennis C, Eddy FD. Response to vagotomy in idiopathic ulcerative colitis. Ann Surg 1948;128:479–86.

    Google Scholar 

  28. Cesnick H. Thymectomy in ulcerative colitis: Promising results in seven patients. Langenbecks Arch Klin Chir 1968;321:86–98.

    Google Scholar 

  29. Sanpanet R, Bucaille M. Procaine injection of the prefrontal lobe of the brain - technic and present indications. Ann Surg 1955;141:388–97.

    Google Scholar 

  30. Crohn BB. Regional ileitis. In: Portis SA, ed. Diseases of the digestive system. Philadelphia: Lea and Febiger, 1941:722–9.

    Google Scholar 

  31. Paulson M. Nonspecific or indeterminate ulcerative colitis. In: Portis SA, ed. Diseases of the digestive system. Philadelphia: Lea and Febiger, 1941:844–71.

    Google Scholar 

  32. Casten D. Nutritional disturbances in regional enteritis. Surgery 1939;6:708–16.

    Google Scholar 

  33. James AH. Breakfast and Crohn’s disease. Br Med J 1977;1:943–5.

    PubMed  CAS  Google Scholar 

  34. Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn’s disease. Klin Wochenschr 1976;54:367–71.

    PubMed  CAS  Google Scholar 

  35. Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn’s disease with an unrefined carbohydrate, fibre rich diet. Br Med J 1979;2:764–6.

    PubMed  CAS  Google Scholar 

  36. Guthy E. Aetiologie der morbus Crohn. Deutsch Med Wochenschr 1983;45: 1729–33.

    Google Scholar 

  37. Andresen AFR. Ulcerative colitis - an allergic phenomenon. Am J Dig Dis 1942;9: 91–8.

    Google Scholar 

  38. Carstensen J. Food additives and their possible role in Crohn’s disease. Z Gastroenterol 1979;(Suppl)17:145–53.

    Google Scholar 

  39. Tilden E, Miller E. The response of the monkey to the withdrawal of vitamin A from the diet. J Nutr 1930;3:121–40.

    CAS  Google Scholar 

  40. Kirsner JB, Sheffner AL, Palmer WL. Studies on amino acid excretion in man. V. Chronic ulcerative colitis and regional enteritis. J Clin Invest 1950;29:874–80.

    PubMed  CAS  Google Scholar 

  41. Kirsner JB, Brandt MB, Sheffner AL. Diet and amino acid utilization in gastrointestinal disorders. J Am Diet Assoc 1953;29:1103–8.

    PubMed  CAS  Google Scholar 

  42. Elman R, Weiner DO. Intravenous alimentation - with special reference to protein (amino acid) metabolism. JAMA 1939;112:796–802.

    CAS  Google Scholar 

  43. Remington JH, Bargen JA, Lundy JS. Amino acid alimentation in gastrointestinal diseases. Gastroenterology 1946;7:442–9.

    PubMed  CAS  Google Scholar 

  44. Machella TE, Miller TG. Treatment of idiopathic ulcerative colitis by means of a “medical ileostomy” and an orally-administered protein hydrolysate-dextrimal-tose mixture. Gastroenterology 1948:10:28–45.

    PubMed  CAS  Google Scholar 

  45. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Longterm total parenteral nutrition with growth, development and positive nitrogen balance. Surgery 1968:64:134–42.

    PubMed  CAS  Google Scholar 

  46. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Can intravenous feeding as the sole means of nutrition support growth in the child and restore weight loss in an adult? An affirmative answer. Ann Surg 1969;169:974–84.

    PubMed  CAS  Google Scholar 

  47. Fisher JE, Foster GS, Abel RM, Abbott WM, Ryan JA. Hyperalimentation as primary therapy for inflammatory bowel disease. Am J Surg 1973:125:165–75.

    Google Scholar 

  48. Vilaseca J, Salas A, Guarner F, Rodriquez R, Martinez M, Malagelada JR. Dietary fish oil reduces progression of chronic inflammatory lesions in rat model of granulomatous colitis. Gut 1990:31:539–44.

    PubMed  CAS  Google Scholar 

  49. Koch TR, Yuan LX, Fink JG, Petro A, Opara EC. Induction of enlarged intestinal lymphoid aggregates during acute glutathione depletion in a murine model. Dig Dis Sci 2000:45:11:2115–21.

    PubMed  CAS  Google Scholar 

  50. Alexander F. The influence of psychologic factors upon gastrointestinal disturbances. A symposium. Psychoanal 0 1934;3:501–39.

    Google Scholar 

  51. Grace WJ, Pinsky RH, Wolff H. Treatment of ulcerative colitis. Gastroenterology 1954;26:462–8.

    PubMed  CAS  Google Scholar 

  52. Karush A, Daniels GE, Flood CF, O’Connor JF, with the assistance of Druss R, Sweeting J. Psychotherapy in chronic ulcerative colitis. Philadelphia: W.B. Saunders, 1977.

    Google Scholar 

  53. Almy TP. Psychosocial aspects of chronic ulcerative colitis and Crohn’s disease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Philadelphia: Lea and Febiger, 1980:44–54.

    Google Scholar 

  54. von Curtius F, Ruhrmoser HG. Zur pscyhotherapie der colitis ulcerosa. Deutsche Med Wochschr 1955;8033:105–8.

    Google Scholar 

  55. Feldman F, Cantor D, Soll S, Bachrach W. Psychiatric study of a consecutive series of 34 patients with ulcerative colitis. Br Med J 1967;3:14–17.

    PubMed  CAS  Google Scholar 

  56. Heizer JE, Stillings WA, Chammas S, Norland CC, Alpers DH. A controlled study of the association between ulcerative colitis and psychiatric diagnoses. Dig Dis Sci 1982;27:513–18.

    Google Scholar 

  57. North CS, Clouse RE, Spitznagel EL, Alpers DH. The relation of ulcerative colitis to psychiatric factors: A review of findings and methods. Am J Psychiatry 1990; 147:974–81.

    PubMed  CAS  Google Scholar 

  58. Heizer JE, Chammas S, Norland CC, Stillings WA, Alpers DH. A study of the association between Crohn’s disease and psychiatric illness. Gastroenterology 1984:86:324–30.

    Google Scholar 

  59. Domagk G. Ein beitrag zur Chemotherapie der bakteriellen infektionen. Dtsch Med Wochenschr 1935;61:250–3.

    CAS  Google Scholar 

  60. Rodaniche EC, Kirsner JB, Palmer WL. Effect of oral administration of sulfona-mide compounds in the fecal flora of patients with nonspecific ulcerative colitis. Gastroenterology 1943;1:133–9.

    Google Scholar 

  61. Marshall HC, Palmer WL, Kirsner JB. Effects of chemotherapeutic agents on fecal bacteria in patients with chronic ulcerative colitis. JAMA 1950;144:900–3.

    Google Scholar 

  62. Cooke EM. Fecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine. Gut 1967;10:565–8.

    Google Scholar 

  63. Svartz N, Kaliner S. Sulfonamide preparations and continued investigations on complications after treatment with brief report on new therapeutic experiments. Forsatta undersokningar over biverkningar vid behandling med sulfonamid-preparat samt en kort redogorelse fur nya terapeutiska forsok. Nord Med 1940; 8:1935–40.

    CAS  Google Scholar 

  64. Svartz N. Salazopyrin - a new sulfanilamide preparation. A. Therapeutic result in rheumatoid arthritis. B. Therapeutic results in ulcerative colitis. C. Toxic manifestations on treatment with sulfanilamide preparations. Acta Med Scand 1942;110:577–90. (also Nord Med 1941;11:2261–2.)

    Google Scholar 

  65. Bachrach WH. Sulfasalalzine. I. An historical perspective. Am J C/astroenterol 1988;83:487–96.

    CAS  Google Scholar 

  66. Svartz N. Sulfasalazine; II. Some notes on the discovery and development of salazopyrin. Am J Gastroenterol 1988;83:497–503.

    PubMed  CAS  Google Scholar 

  67. Bargen JA. Treatment of ulcerative colitis with salicylazosulfapyridine (salazopyrin). Med Clin North Am 1949;33:935–42.

    PubMed  CAS  Google Scholar 

  68. Kirsner JB, Rodaniche EC, Palmer WL. The use of sulfaguanidine in non-specific ulcerative colitis and other infections of the bowel. Am J Dig Dis 1942;9:229–33.

    Google Scholar 

  69. Rodaniche EC, Palmer WL, Kirsner JB. The streptococci present in the feces of patients with nonspecific ulcerative colitis and the effect of oral administration of sulfonamide compounds upon them. J Infect Dis 1943;72:222–7.

    Google Scholar 

  70. Klotz U, Maier K, Fischer C, Heinkel K. Therapeutic efficacy of sulphasalazine and its metabolites in patients with ulcerative colitis and Crohn’s disease. N Engl J Med 1980;303:1499–502.

    PubMed  CAS  Google Scholar 

  71. Peppercorn MA. Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology 1973;64;240–5.

    PubMed  CAS  Google Scholar 

  72. Azad-Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977;2:892–5.

    PubMed  CAS  Google Scholar 

  73. Gaginella TS, Walsh RE. Sulfasalazine - multiplicity of action. Dig Dis Sci 1992; 37:801–12.

    PubMed  CAS  Google Scholar 

  74. Fleming A. The 1928 discovery of penicillin. Br Med Bull 1944;2:4–5.

    Google Scholar 

  75. Fleming A. On the antibacterial action of a penicillium with special reference to their use in the isolation of B. Influenzae. Br J Exp Pathol l929;10:226–38.

    CAS  Google Scholar 

  76. Hench PS, Kendall EC, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex (17-hydroxy-11 Dehydrocorticosterone) (compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis - preliminary report. Proc Staff Meet Mayo Clin 1949;24:181–97.

    CAS  Google Scholar 

  77. Kirsner JB, Palmer WL. Effect of corticotropin (ACTH) in chronic ulcerative colitis. JAMA 1951;147:541–9.

    CAS  Google Scholar 

  78. Truelove SC, Witts IJ. Cortisone in ulcerative colitis. Report on therapeutic trial. Br Med J 1955;2:1041–8.

    PubMed  CAS  Google Scholar 

  79. Goldstein MJ, Gelzayd EA, Kirsner JB. Some observations on the hazards of corticosteroid therapy in patients with inflammatory bowel disease. Trans Am Acad Ophthal Otolaryngol 1967;71:254–61.

    CAS  Google Scholar 

  80. Auphan N, DiDonato JA, Rosette C, Helmberg A, including Karin M. Immuno-suppression by glucocorticoids: inhibition of NF-kappa B activity through induction of IKB synthesis. Science 1995;270:286–90.

    PubMed  CAS  Google Scholar 

  81. Schwartz RS. Immunosuppressive drugs. Prog Allergy 1965;9:246–303.

    CAS  Google Scholar 

  82. Salmonsen CJ, Madsen T. Sur la reproduction de la substance antitoxique apres de fortes saignees. Ann Inst Pasteur 1898;12:763–73.

    Google Scholar 

  83. Hektoen L. Effect of toluene on production of antibodies. J Infect Dis 1911;19: 737–45.

    Google Scholar 

  84. Hektoen L, Corper HJ. Effect of mustard gas on antibody formation. J Infect Dis 1921;28:279–85.

    Google Scholar 

  85. Hitchings GH, Elion GB, Falco EA, Russell PB, VanderWerff H. Studies on analogs of purines and pyrimidines. Ann NY Acad Sci 1950;52:1318–35.

    PubMed  CAS  Google Scholar 

  86. Hitchings GH, Elion GB, Falco EA, Russell PB, Sherwood MB, VanderWerff H. Antagonists of nucleic acid derivatives: lactobacillus casei model. J Biol Chem 1950;183:1–9.

    CAS  Google Scholar 

  87. Elion GB, Bieber S, Hitchings GH. The fate of 6 Mercaptopurine in mice. Ann NY Acad Sci 1954;60:297–302.

    PubMed  CAS  Google Scholar 

  88. Hamilton L, Elion GB. The rate of 6 Mercaptopurine in man. Ann NY Acad Sci 1954;60:304–14.

    PubMed  CAS  Google Scholar 

  89. Schwartz RS, Stack J, Dameshek W. Effect of 6 Mercaptopurine on antibody production. Proc Soc Exp Biol Med 1958;99:164–7.

    PubMed  CAS  Google Scholar 

  90. Page AH, Condie RM, Good RA. Effect of 6 Mercaptopurine on inflammation. Am J Pathol 1962;40:519–30.

    PubMed  CAS  Google Scholar 

  91. Bean RHD. The treatment of chronic ulcerative colitis with 6 Mercaptopurine. Med J Aust 1962;1:592–3.

    Google Scholar 

  92. Bean RHD. Treatment of ulcerative colitis with anti-metabolites. Br Med J 1966; 1:1081–4.

    PubMed  CAS  Google Scholar 

  93. Bowen GE, Irons Jr. GV, Rhodes JB, Kirsner JB. Early experiences with Azathioprine in ulcerative colitis - a note of caution. JAMA 1966;195:460–4.

    PubMed  CAS  Google Scholar 

  94. Rosenberg JL, Levin B, Wall AJ, Kirsner JB. A controlled trial of Azathioprine in Crohn’s disease. Dig Dis 1975;20:721–6.

    CAS  Google Scholar 

  95. Rosenberg JL, Wall AJ, Levin B, Binder HJ, Kirsner JB. A controlled trial of Azathioprine in the management of chronic ulcerative colitis. Gastroenterology 1975;69:96–9.

    PubMed  CAS  Google Scholar 

  96. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn’s disease with 6 Mercaptopurine - a long term randomized double blind study. N Engl J Med 1980;302:981–7.

    PubMed  CAS  Google Scholar 

  97. Winkelman EI, Brown CH. Nitrogen mustard in the treatment of chronic ulcerative colitis and regional enteritis. Cleveland Clinic Q 1965;32:165–74.

    CAS  Google Scholar 

  98. Petcher TJ, Weber HP, Ruegger A. Crystal and molecular structure of an iodo-derivative of the cyclic undecapeptide Cyclosporin A. Helv Chim Acta 1976;59: 1480–9.

    PubMed  CAS  Google Scholar 

  99. Ruegger A, Kuhn M, Lichti H, Loosli HR, Huguenin R, Quiquerez C, et al. Cyclosporin A ein immunosuppressio wirksauer peptimetabolit aus trichoderma polysporium (Link ex Pers.) rifai. Helv Chim Acta 1976;59:1075–92.

    PubMed  CAS  Google Scholar 

  100. Weir RF. A new use for the useless appendix in surgical treatment of obstinate colitis. Med Rec 1902;62:201–2.

    Google Scholar 

  101. Allison CC. Cecostomy: the operation of choice for temporary drainage of the colon. JAMA 1909;53:1562.

    Google Scholar 

  102. Brown JY. The value of complete physiological rest of large bowel in treatment of certain ulcerative and obstructive lesions of this organ. Surg Gynecol Obstet 1913;16:610–13.

    Google Scholar 

  103. Pennel JWC. Stricture of rectum - artificial anus established in left lumbar region. Med Chir Trans 1850;33:255–60.

    Google Scholar 

  104. Franke K. Colectomy or resection of the large intestine for malignant disease. Med Chir 1889;72:211–32. In: Bacon HE. Ulcerative colitis. Philadelphia: Lippincott, 1958.

    Google Scholar 

  105. Bacon HE. Ulcerative colitis. Philadelphia: Lippincott, 1958.

    Google Scholar 

  106. Strombeck JF. Surgical treatment of ulcerative colitis. Acta Chir Scand 1949;98: 414–27.

    PubMed  CAS  Google Scholar 

  107. Strauss AA. Ulcerative colitis. Surg Clin North Am 1923;3:1033–42.

    Google Scholar 

  108. Strauss AA, Friedman J, Block L. Colectomy for ulcerative colitis. Surg Clin North Am 1924;4:667–86.

    Google Scholar 

  109. Hill JL. Ileostomy: surgery, physiology and management. New York: Grune and Stratton, 1976:1–11.

    Google Scholar 

  110. Whittaker LD. Observation on the human being following colectomy or colonic exclusion with ileostomy. Proc Staff Meet Mayo Clin 1937;12:183–7.

    Google Scholar 

  111. Brooke BN, Cooke WT. Ulcerative colitis: diagnostic problems and therapeutic warning. Lancet 1951;2:462–4.

    PubMed  CAS  Google Scholar 

  112. Brooke BN. The management of an ileostomy including its complications. Lancet 1952;2:102–4.

    PubMed  CAS  Google Scholar 

  113. Turnbull RB. Management of an ileostomy. Am J Surg 1953;86:617–24.

    PubMed  Google Scholar 

  114. Patey DH. Primary epithelial apposition in colostomy. Proc Roy Soc Med 1951; 44:423–4.

    PubMed  CAS  Google Scholar 

  115. Coffey RC. Two stage operation in abdominal surgery - making and closing an ileostomy opening. Trans West Surg Assoc 1916;26:159–72.

    Google Scholar 

  116. Aylett S. Diffuse ulcerative colitis and its treatment by ileorectal anastomosis. Ann Roy Coll Surg Engl 1960;27:260–5.

    CAS  Google Scholar 

  117. Kock NG. Continent ileostomy. Progress Surg l973;l2:180–201.

    CAS  Google Scholar 

  118. Ravitch MM, Sabiston DC. Anal ileostomy with preservation of the sphincter. A proposed operation on patients requiring total colectomy for benign lesions. Surg Gynecol Obstet 1947;84:1095–9.

    PubMed  CAS  Google Scholar 

  119. Parks AG, Nicholls RJ, Belliveau P. Proctocolectomy with ileal reservoir and anal anastomosis. Br J Surg 1980;67:533–8.

    PubMed  CAS  Google Scholar 

  120. Dozois RR, Kelly K. Newer operations for ulcerative colitis and Crohn’s disease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Philadelphia: Lea and Febiger, 1988:655–83.

    Google Scholar 

  121. Kelly KA. Anal sphincter-saving operations for chronic ulcerative colitis. Am J Surg 1992;163:5–11.

    PubMed  CAS  Google Scholar 

  122. Glotzer DJ, Glock ME, Goldman H. Proctitis and colitis following diversion of the fecal stream. Gastroenterology 1981;80:438–41.

    PubMed  CAS  Google Scholar 

  123. Korelitz BI, Cheskin LJ, Sohn N, Sommers SC. Proctitis after fecal diversion in Crohn’s disease and its elimination with re-anastomosis - implications for surgical management. Gastroenterology 1984;87:710–13.

    PubMed  CAS  Google Scholar 

  124. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short chain fatty acid irrigation. N Engl J Med 1989;320:23–8.

    PubMed  CAS  Google Scholar 

  125. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1989;21:793–8.

    Google Scholar 

  126. Leonardo RA. Intestinal obstruction due to non-specific ileocecal granulomas (combined “regional ileitis” and colitis). Am J Surg 1937;35:607–8.

    Google Scholar 

  127. Block GE. Surgical management of Crohns colitis. N Engl J Med 1980:302:1068–70.

    PubMed  CAS  Google Scholar 

  128. Kirsner JB. Limitations in the evaluation of therapy for inflammatory bowel disease - suggestions for future research. J Clin Gastroenterol 1990;12:516–24.

    PubMed  CAS  Google Scholar 

  129. Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results and safety. Inflamm Bowel Dis 1990;5:119–33.

    Google Scholar 

  130. Jobin C, Sartor RB. NFKB signalling proteins as therapeutic targets for inflammatory bowel disease. Inflamm Bowel Dis 2000:6:206–13.

    PubMed  CAS  Google Scholar 

  131. Hawkey CJ, Snowden JA, Lobo A, Beglinger C, Tyndall A. Stem cell transplantation for inflammatory bowel disease. Practical and ethical issues. Gut 2000:46: 869–72.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Joseph B. Kirsner M.D., Ph.D., D.Sci. (hon.)
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Kluwer Academic Publishers

About this chapter

Cite this chapter

Kirsner, J.B. (2001). The Early Treatment of Inflammatory Bowel Disease. In: Origins and Directions of Inflammatory Bowel Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0326-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-0326-1_5

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-8777-0

  • Online ISBN: 978-94-010-0326-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation